US › Healthcare

Conduit Pharmaceuticals Inc. (CDT)

US · Healthcare · Biotechnology

$3.14+9.60%

Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue

$750.2M

Revenue YoY

+11.6%

Net profit

$68.5M

Profit YoY

+1237.0%

EPS

$-5.56

Net margin

9.1%

Key statistics

Market cap

$1.8M

Forward P/E

0.0

P/B

0.02

Book value

$223.30

EPS (TTM)

$-81.60

52-week high

$380.00

52-week low

$0.30

50-day MA

$6.52

200-day MA

$232.47

Beta

1.46

Shareholding

Insiders

21.67%

Institutions

0.13%

Largest institutional holders

Fund	Stake
Financial Management Professionals Inc	0.16%
Tower Research Capital LLC	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
Apollon Wealth Management, LLC	0.00%
SBI Securities Co Ltd	0.00%
Virtu Financial LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Conduit Pharmaceuticals Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.